6 hrs ago
Women's Health: As women age, time crunch and life stresses get in the way of self-care
We asked several health professionals, including Hoffman, division chief for women and children at Providence St. Vincent Medical Center, what advice they give women in those years.
10 hrs ago
Smoking, Osteoporosis Link Explained
As people age, bone tends to deteriorate faster, causing osteoporosis and other disorders.
Tue Jun 18, 2013
Osteoporosis Therapy Stops Growth of Breast Cancer Cells
A drug approved in Europe to treat osteoporosis has been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a new study from the Duke Cancer Institute in Durham, N.C. The findings, presented June 15 at the annual Endocrine Society meeting in San Francisco, indicate ... (more)
Mon Jun 17, 2013
Osteoporosis Drug Stops Growth Of Breast Cancer Cells, Even In Resistant Tumors, Study
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study.
Customer Interaction Solutions
Research and Markets: Raloxifene: On the Brink of Expiring - Patent...
Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.
Sat Jun 15, 2013
Bazedoxifene stops resistant breast cancer growth
Bazedoxifene , a drug approved in Europe to treat osteoporosis, has been found to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke University Medical Center Cancer Institute study presented on June 15, 2013, at the annual Endocrine Society meeting in San Francisco.
Thu Jun 13, 2013
Osteoporosis Drug Xgeva Approved By FDA To Treat Giant Cell Bone Tumors
Previously approved by the FDA for osteoporosis and bone metastasis, Xgeva can now also be used for giant cell bone tumors.
Malaysian National News Agency
Almost 50 Per Cent Of Asian Men At Risk Of Poor Bone Health
One in two Asian men could be at risk of developing osteoporosis or other bone-related diseases, said Fonterra, a global leader in dairy nutrition.
Tue Jun 11, 2013
Concern about public safety in osteoporosis clinical trial
'Women's Health Action is concerned that an osteoporosis drug trial run by University of Auckland has exaggerated the risk of osteoporosis to attract women participants and downplayed the risks associated with the trial drug' says Gill Sanson from Women's Health Action Trust.
Sat Jun 08, 2013
New Market Report: EffRx Pharmaceuticals S.A. - Pharmaceuticals &...
It focuses on metabolic bone disease, pediatric medications and cancer supportive care.
Thu Jun 06, 2013
Aging and Bone Loss Worries? Supplements Not Always Sufficent
Medical experts and your mother's common sense agree that Calcium and Vitamin D are critical for healthy bones, and that you should get as much of these nutrients as possible from a good diet.
Osteoporosis Drug Aids Young People With Cystic Fibrosis Not Helped By Standard Treatments
The first randomised trial to investigate the treatment of low bone density in young people with cystic fibrosis , published Online First in The Lancet Respiratory Medicine , provides compelling evidence that alendronate is safe and can help increase bone mineral density in young patients with CF after standard treatment with calcium and vitamin D ... (more)
Wed Jun 05, 2013
Aging & Bone Loss Worries? Calcium and Vitamin D Not Always the Answer
Calcium and Vitamin D are critical for healthy bones, and medical experts agree that you should get as much of these nutrients as possible from a good diet.
Fri May 31, 2013
IOF Worldwide Conference of Osteoporosis Patient Societies opens in Helsinki
Distinguished women leaders open conference, urge 'strong bones for strong women' to reduce the growing burden of osteoporosis and fractures More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.
Wed May 29, 2013
The Washington Post
Amgen, Astellas to Develop Cancer, Bone Treatments in Japan
Amgen Inc., the world's largest biotechnology company by sales, announced a partnership with Japanese drugmaker Astellas Pharma Inc.
Tue May 28, 2013
Market Report, "PharmaPoint: Osteoporosis - France Drug Forecast and...
PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, "PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022". Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022.
Fri May 24, 2013
Winteam to Buy Tongjitang Medicine for $393 Million
Winteam Pharmaceutical Group Ltd. , a maker of drugs in China , will buy a producer of traditional Chinese medicine for as much as HK$3.05 billion to gain products including an osteoporosis treatment.
Thu May 23, 2013
For the Refrigerator Door: You have osteoporosis, now what?
About 10 million Americans have the condition that occurs when bones become weak, brittle and likely to break.
Wed May 22, 2013
OsteoGeneX gets nearly $500K grant for bone disease work
The National Institutes of Health awarded $475,076 to OsteoGeneX Inc., a Kansas City, Kan., private pharmaceutical company focused on developing a treatment for osteoporosis.